Indivior Pharmaceuticals (INDV) Change in Acquisitions & Divestments (2024 - 2026)

Indivior Pharmaceuticals' Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $6.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments changed 0.0% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $19.0 million (up 176.0% YoY), while the FY2025 annual figure was $19.0 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments was $6.0 million for Q1 2026 at Indivior Pharmaceuticals, up from $5.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $46.0 million in Q3 2024 to a low of -$88.0 million in Q4 2024.
• Historically, Change in Acquisitions & Divestments has averaged $2.8 million across 3 years, with a median of $6.0 million in 2025.
• Biggest YoY gain for Change in Acquisitions & Divestments was 105.68% in 2025; the steepest drop was 93.48% in 2025.
• A 3-year view of Change in Acquisitions & Divestments shows it stood at -$88.0 million in 2024, then surged by 105.68% to $5.0 million in 2025, then gained by 20.0% to $6.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $6.0 million (Q1 2026), $5.0 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.